Interpol Highlights Takedown Of Deadly Global Fake Food And Drink Operations 25/04/2018 William New Weevil-infested flour, deadly methanol added to alcohol, borax to make products seem fresher, pesticide-laced shrimp, fake medicines. Global police organisation Interpol today detailed a multi-agency operation that dismantled nearly 50 criminal networks worldwide that provided fake and substandard food and drink that put people in danger and killed dozens. Continue reading -> Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Study: Global Consumption Of Antibiotics Rising, In Particular In LMICs; Policy Change Needed 12/04/2018 Catherine Saez In the face of the growing threat of antimicrobial resistance, a recent study of the Proceedings of the National Academy of Sciences of the United States of America (PNSA) found that the antibiotic consumption rate in low and middle-income countries has substantially increased in recent years. At the same time, inequities in drug access persist in many countries, with high rates of infectious disease-related mortality, according to the study. Continue reading -> UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 William New The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments. Continue reading -> Pharma, Nonprofits Collaborate On Affordable Hepatitis C Treatment In Latin America 06/03/2018 William New The Drugs for Neglected Disease initiative (DNDi), a nonprofit research and development organisation, today announced a collaboration with pharmaceutical companies and other nonprofits to manufacture and supply a "new, more affordable" hepatitis C treatment in Latin America. Hepatitis C medicines have been renowned for their high prices worldwide. Continue reading -> WHO Joint Tropical Disease Program Issues Report On Research Fairness 02/03/2018 William New The World Health Organisation's Special Programme for Research and Training in Tropical Diseases (TDR) has published the first report on research fairness under a new initiative. The report includes an analysis of how TDR manages intellectual property rights in a positive way. Continue reading -> Video Gaming Industry Issues Attack On WHO’s Proposed Gaming Disorder Classification 01/03/2018 William New Teens' (and others') life-altering obsession with video gaming is well-known to almost any parent in most countries around the world, and the World Health Organization recently identified it as an addiction called "gaming disorder." Today, the self-acclaimed $36 billion video gaming industry hit back with a statement about a new paper from "preeminent researchers and scientists" that it says casts doubt on the WHO's efforts. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Posts navigation Older postsNewer posts
Hope For Hepatitis C Patients In Poor Countries – New Affordable Combination With High Cure Rate 12/04/2018 Catherine Saez A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced today. Continue reading -> Study: Global Consumption Of Antibiotics Rising, In Particular In LMICs; Policy Change Needed 12/04/2018 Catherine Saez In the face of the growing threat of antimicrobial resistance, a recent study of the Proceedings of the National Academy of Sciences of the United States of America (PNSA) found that the antibiotic consumption rate in low and middle-income countries has substantially increased in recent years. At the same time, inequities in drug access persist in many countries, with high rates of infectious disease-related mortality, according to the study. Continue reading -> UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 William New The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments. Continue reading -> Pharma, Nonprofits Collaborate On Affordable Hepatitis C Treatment In Latin America 06/03/2018 William New The Drugs for Neglected Disease initiative (DNDi), a nonprofit research and development organisation, today announced a collaboration with pharmaceutical companies and other nonprofits to manufacture and supply a "new, more affordable" hepatitis C treatment in Latin America. Hepatitis C medicines have been renowned for their high prices worldwide. Continue reading -> WHO Joint Tropical Disease Program Issues Report On Research Fairness 02/03/2018 William New The World Health Organisation's Special Programme for Research and Training in Tropical Diseases (TDR) has published the first report on research fairness under a new initiative. The report includes an analysis of how TDR manages intellectual property rights in a positive way. Continue reading -> Video Gaming Industry Issues Attack On WHO’s Proposed Gaming Disorder Classification 01/03/2018 William New Teens' (and others') life-altering obsession with video gaming is well-known to almost any parent in most countries around the world, and the World Health Organization recently identified it as an addiction called "gaming disorder." Today, the self-acclaimed $36 billion video gaming industry hit back with a statement about a new paper from "preeminent researchers and scientists" that it says casts doubt on the WHO's efforts. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Posts navigation Older postsNewer posts
Study: Global Consumption Of Antibiotics Rising, In Particular In LMICs; Policy Change Needed 12/04/2018 Catherine Saez In the face of the growing threat of antimicrobial resistance, a recent study of the Proceedings of the National Academy of Sciences of the United States of America (PNSA) found that the antibiotic consumption rate in low and middle-income countries has substantially increased in recent years. At the same time, inequities in drug access persist in many countries, with high rates of infectious disease-related mortality, according to the study. Continue reading -> UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 William New The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments. Continue reading -> Pharma, Nonprofits Collaborate On Affordable Hepatitis C Treatment In Latin America 06/03/2018 William New The Drugs for Neglected Disease initiative (DNDi), a nonprofit research and development organisation, today announced a collaboration with pharmaceutical companies and other nonprofits to manufacture and supply a "new, more affordable" hepatitis C treatment in Latin America. Hepatitis C medicines have been renowned for their high prices worldwide. Continue reading -> WHO Joint Tropical Disease Program Issues Report On Research Fairness 02/03/2018 William New The World Health Organisation's Special Programme for Research and Training in Tropical Diseases (TDR) has published the first report on research fairness under a new initiative. The report includes an analysis of how TDR manages intellectual property rights in a positive way. Continue reading -> Video Gaming Industry Issues Attack On WHO’s Proposed Gaming Disorder Classification 01/03/2018 William New Teens' (and others') life-altering obsession with video gaming is well-known to almost any parent in most countries around the world, and the World Health Organization recently identified it as an addiction called "gaming disorder." Today, the self-acclaimed $36 billion video gaming industry hit back with a statement about a new paper from "preeminent researchers and scientists" that it says casts doubt on the WHO's efforts. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Posts navigation Older postsNewer posts
UAEM Students Launch Campaign To Drop Publicly Funded Patent Claim On Cancer Drug In India 16/03/2018 William New The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University of California to drop its pursuit of a patent on the prostrate cancer drug Xtandi in India in order to make it affordable for patients. Xtandi sells at "exorbitant" rates in the United States, they said, a seeming violation of the licensing guidelines of the publicly funded University of California system which guarantees an "appropriate" return on taxpayer investments. Continue reading -> Pharma, Nonprofits Collaborate On Affordable Hepatitis C Treatment In Latin America 06/03/2018 William New The Drugs for Neglected Disease initiative (DNDi), a nonprofit research and development organisation, today announced a collaboration with pharmaceutical companies and other nonprofits to manufacture and supply a "new, more affordable" hepatitis C treatment in Latin America. Hepatitis C medicines have been renowned for their high prices worldwide. Continue reading -> WHO Joint Tropical Disease Program Issues Report On Research Fairness 02/03/2018 William New The World Health Organisation's Special Programme for Research and Training in Tropical Diseases (TDR) has published the first report on research fairness under a new initiative. The report includes an analysis of how TDR manages intellectual property rights in a positive way. Continue reading -> Video Gaming Industry Issues Attack On WHO’s Proposed Gaming Disorder Classification 01/03/2018 William New Teens' (and others') life-altering obsession with video gaming is well-known to almost any parent in most countries around the world, and the World Health Organization recently identified it as an addiction called "gaming disorder." Today, the self-acclaimed $36 billion video gaming industry hit back with a statement about a new paper from "preeminent researchers and scientists" that it says casts doubt on the WHO's efforts. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Posts navigation Older postsNewer posts
Pharma, Nonprofits Collaborate On Affordable Hepatitis C Treatment In Latin America 06/03/2018 William New The Drugs for Neglected Disease initiative (DNDi), a nonprofit research and development organisation, today announced a collaboration with pharmaceutical companies and other nonprofits to manufacture and supply a "new, more affordable" hepatitis C treatment in Latin America. Hepatitis C medicines have been renowned for their high prices worldwide. Continue reading -> WHO Joint Tropical Disease Program Issues Report On Research Fairness 02/03/2018 William New The World Health Organisation's Special Programme for Research and Training in Tropical Diseases (TDR) has published the first report on research fairness under a new initiative. The report includes an analysis of how TDR manages intellectual property rights in a positive way. Continue reading -> Video Gaming Industry Issues Attack On WHO’s Proposed Gaming Disorder Classification 01/03/2018 William New Teens' (and others') life-altering obsession with video gaming is well-known to almost any parent in most countries around the world, and the World Health Organization recently identified it as an addiction called "gaming disorder." Today, the self-acclaimed $36 billion video gaming industry hit back with a statement about a new paper from "preeminent researchers and scientists" that it says casts doubt on the WHO's efforts. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Posts navigation Older postsNewer posts
WHO Joint Tropical Disease Program Issues Report On Research Fairness 02/03/2018 William New The World Health Organisation's Special Programme for Research and Training in Tropical Diseases (TDR) has published the first report on research fairness under a new initiative. The report includes an analysis of how TDR manages intellectual property rights in a positive way. Continue reading -> Video Gaming Industry Issues Attack On WHO’s Proposed Gaming Disorder Classification 01/03/2018 William New Teens' (and others') life-altering obsession with video gaming is well-known to almost any parent in most countries around the world, and the World Health Organization recently identified it as an addiction called "gaming disorder." Today, the self-acclaimed $36 billion video gaming industry hit back with a statement about a new paper from "preeminent researchers and scientists" that it says casts doubt on the WHO's efforts. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Posts navigation Older postsNewer posts
Video Gaming Industry Issues Attack On WHO’s Proposed Gaming Disorder Classification 01/03/2018 William New Teens' (and others') life-altering obsession with video gaming is well-known to almost any parent in most countries around the world, and the World Health Organization recently identified it as an addiction called "gaming disorder." Today, the self-acclaimed $36 billion video gaming industry hit back with a statement about a new paper from "preeminent researchers and scientists" that it says casts doubt on the WHO's efforts. Continue reading -> CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Posts navigation Older postsNewer posts
CARB-X Announces 2018 Round Of Funding For Antibacterial Research 23/02/2018 William New CARB-X , a global private-public partnership for research on antimicrobial resistance, this week announced its 2018 rounds of funding for research on "antibiotics, vaccines, diagnostics, devices and other life-saving products to respond to the threat of drug-resistant bacteria." Continue reading -> New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Posts navigation Older postsNewer posts
New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 William New A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a "devastating disease for which current treatments are ineffective, expensive, and toxic," the group said. Continue reading -> Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Posts navigation Older postsNewer posts
Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 William New Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance. Continue reading -> Posts navigation Older postsNewer posts